CIK 0001357874
- Non-accelerated filer
- Smaller reporting company
PRECISION BIOSCIENCES INC
Sign in to watch- Ticker
- DTIL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- May 21
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 919-314-5512
- Business address
- 302 EAST PETTIGREW STREET, SUITE A-100, DURHAM, NC, 27701
- Open-market buys, last 90 days
- $29,501
- in 3 filings
- Open-market sales, last 90 days
- $27,505
- in 1 filing, $28K under 10b5-1 plans
Net +$1,996. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 39 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-26 | Barton Shane VP & Corporate Controller | Grant or award | +1,294 | $4.61 | $6K | 1,294 |
| 2021-02-26 | Scimeca Dario General Counsel and Secretary | Grant or award | +2,748 | $4.61 | $13K | 7,976 |
| 2021-02-22 | JANTZ DEREK Chief Scientific Officer | Option exercise | +21,514 | $0.04 | $861 | 3,955,353 |
| 2021-02-22 | JANTZ DEREK Chief Scientific Officer | Sale | −9,660 | $12.04 | $116K | 3,945,693 |
| 2021-02-19 | JANTZ DEREK Chief Scientific Officer | Option exercise | +21,514 | $0.04 | $861 | 3,943,502 |
| 2021-02-19 | JANTZ DEREK Chief Scientific Officer | Sale | −9,663 | $11.55 | $112K | 3,933,839 |
| 2021-02-19 | JANTZ DEREK Chief Scientific Officer | Option exercise · Employee Stock Option (Right to Buy) | −21,514 | 215,140 | ||
| 2021-02-18 | JANTZ DEREK Chief Scientific Officer | Option exercise | +21,514 | $0.04 | $861 | 3,928,859 |
| 2021-02-18 | JANTZ DEREK Chief Scientific Officer | Sale | −6,871 | $12.20 | $84K | 3,921,988 |
| 2021-02-18 | JANTZ DEREK Chief Scientific Officer | Option exercise · Employee Stock Option (Right to Buy) | −21,514 | 236,654 | ||
| 2021-02-18 | KANE MATTHEW R. President and CEO | Option exercise | +21,514 | $0.04 | $861 | 1,899,151 |
| 2021-02-18 | KANE MATTHEW R. President and CEO | Sale | −9,705 | $12.23 | $119K | 1,889,446 |
| 2021-02-18 | KANE MATTHEW R. President and CEO | Option exercise · Employee Stock Option (Right to Buy) | −21,514 | 193,626 | ||
| 2020-08-31 | Scimeca Dario General Counsel and Secretary | Grant or award | +3,156 | $4.79 | $15K | 5,228 |
| 2020-08-21 | KANE MATTHEW R. President and CEO | Grant or award · Employee Stock Option (Right to Buy) | +1,743 | 1,743 | ||
| 2020-02-28 | Scimeca Dario General Counsel and Secretary | Grant or award | +2,072 | $5.61 | $12K | 2,072 |
Page 23 of 23 · 456 trades